SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Renumathy Dhanasekaran, William Sanchez, Taofic Mounajjed, Russell H. Wiesner, Kymberly D. Watt, Michael R. Charlton, Impact of fibrosis progression on clinical outcome in patients treated for post- transplant hepatitis C recurrence, Liver International, 2015, 35, 9
  2. 2
    Iram Siddiqui, Nazia Selzner, Sara Hafezi-Bakhtiari, Max A Marquez, Oyedele A Adeyi, Infiltrative (sinusoidal) and hepatitic patterns of injury in acute cellular rejection in liver allograft with clinical implications, Modern Pathology, 2015,

    CrossRef

  3. 3
    Toru Ikegami, Tomoharu Yoshizumi, Yoshihro Yoshida, Takeshi Kurihara, Norifumi Harimoto, Shinji Itoh, Masahiro Shimokawa, Takasuke Fukuhara, Ken Shirabe, Yoshihiko Maehara, Telaprevir versus simeprevir for the treatment of recurrent hepatitis C after living donor liver transplantation, Hepatology Research, 2015, 45, 8
  4. 4
    Bita V. Naini, Charles R. Lassman, Transplantation of the Liver, 2015,

    CrossRef

  5. 5
    Anthony J. Demetris, Marta I. Minervini, Michael A. Nalesnik, Parmjeet Randhawa, Eizaburo Sasatomi, Transplantation of the Liver, 2015,

    CrossRef

  6. 6
    Toru Ikegami, Tomoharu Yoshizumi, Ken Shirabe, Yoshihiko Maehara, Frequent plasma cell hepatitis during telaprevir-based triple therapy for hepatitis C after liver transplantation, Journal of Hepatology, 2014, 60, 4, 894

    CrossRef

  7. 7
    Julie A. Thompson, John R. Lake, Interferon graft dysfunction: a final chapter for interferon and hepatitis C, Hepatology International, 2014, 8, 2, 155

    CrossRef

  8. You have free access to this content8
    Yoshihide Ueda, Atsushi Yoshizawa, Yasuhiro Ogura, Aya Miyagawa-Hayashino, Hironori Haga, Tsutomu Chiba, Shinji Uemoto, Plasma cell hepatitis induced by the termination of antiviral therapy for recurrent hepatitis C after living donor liver transplantation, Hepatology Research, 2014, 44, 10
  9. 9
    Audrey Coilly, Mylène Sebagh, Jean-Charles Duclos-Vallée, Reply to: “Frequent plasma cell hepatitis during telaprevir-based triple therapy for hepatitis C after liver transplantation”, Journal of Hepatology, 2014, 60, 4, 896

    CrossRef

  10. 10
    Toru Ikegami, Huanlin Wang, Tomoharu Yoshizumi, Takeo Toshima, Shinichi Aishima, Takasuke Fukuhara, Norihiro Furusyo, Kazuhiro Kotoh, Shinji Shimoda, Ken Shirabe, Yoshihiko Maehara, Strategies to treat interferon-induced graft dysfunction after living donor liver transplantation for hepatitis C, Hepatology International, 2014, 8, 2, 285

    CrossRef

  11. 11
    M. Castillo-Rama, M. Sebagh, E. Sasatomi, P. Randhawa, K. Isse, A. D. Salgarkar, K. Ruppert, A. Humar, A. J. Demetris, “Plasma Cell Hepatitis” in Liver Allografts: Identification and Characterization of an IgG4-Rich Cohort, American Journal of Transplantation, 2013, 13, 11
  12. 12
    Mylène Sebagh, Marcela Castillo-Rama, Daniel Azoulay, Audrey Coilly, Valérie Delvart, Marc-Antoine Allard, Alexandre Dos Santos, Catherine Johanet, Anne-Marie Roque-Afonso, Faouzi Saliba, Jean-Charles Duclos-Vallée, Didier Samuel, Anthony Jack Demetris, Histologic Findings Predictive of a Diagnosis of De novo Autoimmune Hepatitis After Liver Transplantation in Adults, Transplantation Journal, 2013, 96, 7, 670

    CrossRef

  13. 13
    X.-y. Zhao, M.I.A. Rakhda, T.-I. Wang, J.-d. Jia, Immunoglobulin G4-Associated De Novo Autoimmune Hepatitis After Liver Transplantation for Chronic Hepatitis B- and C-Related Cirrhosis and Hepatocellular Carcinoma: A Case Report With Literature Review, Transplantation Proceedings, 2013, 45, 2, 824

    CrossRef

  14. 14
    Pratima Sharma, Amy Hosmer, Henry Appelman, Barbara McKenna, Mohammad S. Jafri, Patricia Sullivan, Robert J. Fontana, Anna S. Lok, Immunological dysfunction during or after antiviral therapy for recurrent hepatitis C reduces graft survival, Hepatology International, 2013, 7, 4, 990

    CrossRef

  15. 15
    María-Carlota Londoño Hurtado, Lesiones histológicas en el injerto en pacientes con supervivencia prolongada tras el trasplante hepático: ¿son necesarias biopsias de protocolo?, Gastroenterología y Hepatología, 2013, 36, 2, 97

    CrossRef

  16. 16
    Bita V. Naini, Charles R. Lassman, Liver Transplant Pathology, Surgical Pathology Clinics, 2013, 6, 2, 277

    CrossRef

  17. You have free access to this content17
    Michael R. Lucey, Norah Terrault, Lolu Ojo, J. Eileen Hay, James Neuberger, Emily Blumberg, Lewis W. Teperman, Long-term management of the successful adult liver transplant: 2012 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation, Liver Transplantation, 2013, 19, 1
  18. 18
    Miguel Jiménez-Pérez, Francisco Javier Rando-Muñoz, Rocío González-Grande, Fernando González-Panizo Tamargo, Jesús de la Cruz Lombardo, Juan Miguel Rodrigo López, Román Manteca González, Post-transplant plasma cell hepatitis in a liver transplant patient treated with pegylated interferon plus ribavirin, Open Journal of Gastroenterology, 2013, 03, 07, 307

    CrossRef

  19. You have free access to this content19
    D. Joshi, I. Carey, K. Agarwal, Review article: the treatment of genotype 1 chronic hepatitis C virus infection in liver transplant candidates and recipients, Alimentary Pharmacology & Therapeutics, 2013, 37, 7
  20. 20
    Ji-Yuan Zhang, Yuan-Yuan Li, Zheng Zhang, Fu-Sheng Wang, The prediction of immunological dysfunction during antiviral therapy for HCV after liver transplantation: can we improve outcomes?, Hepatology International, 2013, 7, 4, 948

    CrossRef

  21. 21
    Rodrigo Liberal, Maria Serena Longhi, Charlotte R. Grant, Giorgina Mieli–Vergani, Diego Vergani, Autoimmune Hepatitis After Liver Transplantation, Clinical Gastroenterology and Hepatology, 2012, 10, 4, 346

    CrossRef

  22. 22
    Hind I. Fallatah, Hisham O. Akbar, Autoimmune Hepatitis as a Unique Form of an Autoimmune Liver Disease: Immunological Aspects and Clinical Overview, Autoimmune Diseases, 2012, 2012, 1

    CrossRef

  23. 23
    Albert J. Czaja, Diagnosis, Pathogenesis, and Treatment of Autoimmune Hepatitis After Liver Transplantation, Digestive Diseases and Sciences, 2012, 57, 9, 2248

    CrossRef

  24. 24
    Nedim Hadžić, Alberto Quaglia, Corina Cotoi, Munther J. Hussain, Nigel Brown, Diego Vergani, Giorgina Mieli-Vergani, Immunohistochemical phenotyping of the inflammatory infiltrate in de novo autoimmune hepatitis after liver transplantation in children, Pediatric Transplantation, 2012, 16, 5
  25. 25
    Anthony Demetris, Importance of liver biopsy findings in immunosuppression management: Biopsy monitoring and working criteria for patients with operational tolerance, Liver Transplantation, 2012, 18, 10
  26. 26
    Aldo J. Montano-Loza, Florencia Vargas-Vorackova, Mang Ma, Vincent G. Bain, Kelly Burak, Thara Kumar, Andrew L. Mason, Incidence and risk factors associated with de novo autoimmune hepatitis after liver transplantation, Liver International, 2012, 32, 9
  27. 27
    Norah Terrault, Liver transplantation in the setting of chronic HCV, Best Practice & Research Clinical Gastroenterology, 2012, 26, 4, 531

    CrossRef

  28. 28
    M. Isabel Fiel, Thomas D. Schiano, Plasma cell hepatitis (de-novo autoimmune hepatitis) developing post liver transplantation, Current Opinion in Organ Transplantation, 2012, 17, 3, 287

    CrossRef

  29. 29
    Shishir Shetty, David H Adams, Stefan G Hubscher, Post-transplant liver biopsy and the immune response: lessons for the clinician, Expert Review of Clinical Immunology, 2012, 8, 7, 645

    CrossRef

  30. 30
    Josh Levitsky, Maria Isabel Fiel, John P. Norvell, Edward Wang, Kymberly D. Watt, Michael P. Curry, Sumeet Tewani, Timothy M. McCashland, Maarouf A. Hoteit, Abraham Shaked, Samuel Saab, Amanda C. Chi, Amy Tien, Thomas D. Schiano, Risk for Immune-Mediated Graft Dysfunction in Liver Transplant Recipients With Recurrent HCV Infection Treated With Pegylated Interferon, Gastroenterology, 2012, 142, 5, 1132

    CrossRef

  31. 31
    Jacob Alexander, Wenjiang Chu, Paul E. Swanson, Matthew M. Yeh, The significance of plasma cell infiltrate in acute cellular rejection of liver allografts, Human Pathology, 2012, 43, 10, 1645

    CrossRef

  32. 32
    Stefan G. Hübscher, Andrew D. Clouston, MacSween's Pathology of the Liver, 2012,

    CrossRef

  33. 33
    M. Kay Washington, Michael P. Manns, MacSween's Pathology of the Liver, 2012,

    CrossRef

  34. 34
    Mohammad Hossein Sanei, Thomas D. Schiano, Christine Sempoux, Cathy Fan, M. Isabel Fiel, Acute Cellular Rejection Resulting in Sinusoidal Obstruction Syndrome and Ascites Postliver Transplantation, Transplantation, 2011, 92, 10, 1152

    CrossRef

  35. 35
    T. Casanovas, A. Argudo, M.C. Peña-Cala, Effectiveness and Safety of Everolimus in the Treatment of Autoimmune Hepatitis Related to Anti-Hepatitis C Virus Therapy After Liver Transplant: Three Case Reports, Transplantation Proceedings, 2011, 43, 6, 2233

    CrossRef

  36. 36
    Shari L Taylor, Salima Haque, Hepatobiliary pathology, Current Opinion in Gastroenterology, 2011, 27, 3, 248

    CrossRef

  37. 37
    Nazia Selzner, Maha Guindi, Eberhard L. Renner, Marina Berenguer, Immune-mediated complications of the graft in interferon-treated hepatitis C positive liver transplant recipients, Journal of Hepatology, 2011, 55, 1, 207

    CrossRef

  38. 38
    Roger Klein Moreira, Recurrent Hepatitis C and Acute Allograft Rejection, Advances In Anatomic Pathology, 2011, 18, 5, 393

    CrossRef

  39. 39
    Stefan G. Hübscher, What is the long-term outcome of the liver allograft?, Journal of Hepatology, 2011, 55, 3, 702

    CrossRef

  40. 40
    Romil Saxena, Swan N. Thung, Practical Hepatic Pathology: A Diagnostic Approach, 2011,

    CrossRef

  41. 41
    Ye H. Oo, Stefan G. Hubscher, David H. Adams, Autoimmune hepatitis: new paradigms in the pathogenesis, diagnosis, and management, Hepatology International, 2010, 4, 2, 475

    CrossRef

  42. You have free access to this content42
    Desley A. H. Neil, Stefan G. Hübscher, Current views on rejection pathology in liver transplantation, Transplant International, 2010, 23, 10
  43. 43
    Albert J Czaja, Autoimmune liver disease, Current Opinion in Gastroenterology, 2009, 25, 3, 215

    CrossRef

  44. 44
    Albert J Czaja, Current and future treatments of autoimmune hepatitis, Expert Review of Gastroenterology & Hepatology, 2009, 3, 3, 269

    CrossRef

  45. 45
    Anthony J. Demetris, Evolution of hepatitis C virus in liver allografts, Liver Transplantation, 2009, 15, S2
  46. 46
    Hui-Hui Tan, M. Isabel Fiel, Juan del Rio Martin, Thomas D. Schiano, Graft rejection occurring in post–liver transplant patients receiving cytotoxic chemotherapy: A case series, Liver Transplantation, 2009, 15, 6
  47. 47
    Stephen C. Ward, Thomas D. Schiano, Swan N. Thung, M. Isabel Fiel, Plasma cell hepatitis in hepatitis C virus patients post–liver transplantation: Case-control study showing poor outcome and predictive features in the liver explant, Liver Transplantation, 2009, 15, 12
  48. 48
    Jay H. Lefkowitch, Recent developments in liver pathology, Human Pathology, 2009, 40, 4, 445

    CrossRef

  49. 49
    Zu-hua Gao, Seeking Beyond Rejection: An Update on the Differential Diagnosis and a Practical Approach to Liver Allograft Biopsy Interpretation, Advances in Anatomic Pathology, 2009, 16, 2, 97

    CrossRef

  50. 50
    C. Rigamonti, M. Vidali, M. F. Donato, S. Sutti, G. Occhino, A. Ivaldi, E. Arosio, F. Agnelli, G. Rossi, M. Colombo, E. Albano, Serum Autoantibodies Against Cytochrome P450 2E1 (CYP2E1) Predict Severity of Necroinflammation of Recurrent Hepatitis C, American Journal of Transplantation, 2009, 9, 3
  51. 51
    Anthony J. Demetris, Mylene Sebagh, Plasma cell hepatitis in liver allografts: Variant of rejection or autoimmune hepatitis?, Liver Transplantation, 2008, 14, 6
  52. 52
    Anthony J. Demetris, Marta I. Minervini, Michael A. Nalesnik, Erin Rubin, Parmjeet Randhawa, Eizaburo Sasatomi, Histopathological Syndromes of Liver Allograft Rejection and Recurrent Disease,
  53. 53
    Kiran Bambha, Norah A. Terrault, Long-Term Management of Recurrent Primary Liver Disease,
  54. 54
    Brett E Fortune, Hugo R Rosen, James R Burton, Management of HCV Infection and Liver Transplantation,